B.Sc. [Mathematics and biology] (University of British Columbia), M.P.H. [Biostatistics] (University of British Columbia), Ph.D. [Epidemiology/biostatistics] (University of British Columbia)
Assistant Professor, Faculty of Pharmaceutical Sciences, University of British Columbia
Research InterestsData Science; Drug Effectiveness; Drug Safety; Epidemiology; SCI Progression
Dr. Jacquelyn Cragg aims to be a world leader in neuro-analytics, helping to uncover innovative treatment strategies and therapies for people suffering from neurological diseases. She is working with statistical algorithms to better understand neurological diseases, including Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and SCI.
Dr. Jacquelyn Cragg is an Assistant Professor in UBC’s Faculty of Pharmaceutical Sciences and a Principal Investigator at ICORD. She is leveraging clinical and population “big data” sources and machine-based learning to identify novel, reliable predictors of spinal cord injury progression. She also researches other neurological diseases beyond spinal cord injury, such as Parkinson’s disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS).
As the sole North American recipient of L’Oréal-UNESCO for Women In Science International Rising Talent Prize for 2019, Dr. Cragg is a champion for encouraging women and girls to pursue careers in science.
Techniques employed in the Lab
- Longitudinal analysis
- Statistical learning
- Recursive partitioning
- Survival analysis
- Causal inference
Some of Dr. Cragg’s recent major awards and accomplishments include:
- Tier 2 Canada Research Chair (Canada Research Chairs, 2020-2025)
Current Lab Members
|Masters Students||Residents||Ph.D. Students||Postdoctoral Fellows||Research Staff|
|Analisa Jia||Sina Marzoughi||Jan Rosner||Dr. James Crispo||Lisa Liu|
|Anh Khoa Vo||Lisa Kuramoto|
|2021||Analisa Jia||3 Minute Thesis (3MT), Faculty of Pharmaceutical Sciences, 1st Prize (UBC PharmSci, 2021)|
|2020||Analisa Jia||Summer Student Research Program 1st Prize (poster presentation) (UBC PharmSci, 2020)|
Current Opportunities in the Lab
There are currently no openings in Dr. Cragg’s lab. Please contact Dr. Cragg with inquiries.
- Kuramoto, LK et al.. 2021. A systematic, concept-based method of developing the exposure measure for drug safety and effectiveness studies.. Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.5372.
- Kelly, DJ et al.. 2021. Readmission Following Hospitalization for Traumatic Brain Injury: A Nationwide Study.. J Head Trauma Rehabil. doi: 10.1097/HTR.0000000000000699.
- Aspinall, P et al.. 2021. A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations.. J Neurotrauma. doi: 10.1089/neu.2020.7540.
- Marzoughi, S et al.. 2021. Tardive neurotoxicity of anticholinergic drugs: A review.. J Neurochem. doi: 10.1111/jnc.15244.
- Cragg, JJ et al.. 2021. The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines.. Expert Opin Drug Saf. doi: 10.1080/14740338.2021.1849134.